Philip Scheltens, MD, PhD from the VU University Medical Center, Amsterdam, Netherlands discusses his talk on cerebrospinal fluid (CSF) and imaging biomarkers in the differential diagnosis of dementia held at the 2017 Congress of the European Academy of Neurology (EAN) in Amsterdam, the Netherlands. Prof. Scheltens explains that the diagnosis can now be made not only on a clinical level, but also a pathological level with, for example, tau and amyloid PET imaging.
